Angelo Ravelli
#131,143
Most Influential Person Now
Researcher
Angelo Ravelli's AcademicInfluence.com Rankings
Angelo Ravellicomputer-science Degrees
Computer Science
#5774
World Rank
#6095
Historical Rank
Computational Linguistics
#878
World Rank
#891
Historical Rank
Machine Learning
#1654
World Rank
#1676
Historical Rank
Artificial Intelligence
#1890
World Rank
#1922
Historical Rank
Download Badge
Computer Science
Angelo Ravelli's Degrees
- PhD Computer Science University of Milan
- Masters Computer Science University of Milan
- Bachelors Computer Science University of Milan
Similar Degrees You Can Earn
Why Is Angelo Ravelli Influential?
(Suggest an Edit or Addition)Angelo Ravelli's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Preliminary definition of improvement in juvenile arthritis. (1997) (1068)
- EULAR/PReS endorsed consensus criteria* for the classification of childhood vasculitides (2005) (754)
- Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis. (2012) (702)
- Juvenile Idiopathic Arthritis (2000) (697)
- Development and validation of a composite disease activity score for juvenile idiopathic arthritis. (2009) (578)
- On the Alert for Cytokine Storm: Immunopathology in COVID‐19 (2020) (562)
- 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative (2016) (486)
- Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. (2005) (400)
- A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis. (2007) (377)
- The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis. (2008) (355)
- Cross-cultural adaptation and psychometric evaluation of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ) in 32 countries. Review of the general methodology. (2001) (354)
- Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment (2012) (317)
- Clinical Features, Treatment, and Outcome of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A Multinational, Multicenter Study of 362 Patients (2014) (293)
- Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients. (2009) (243)
- 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis (2016) (236)
- Patterns of clinical remission in select categories of juvenile idiopathic arthritis. (2005) (228)
- Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus (2018) (219)
- Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. (2003) (213)
- Patients with antinuclear antibody-positive juvenile idiopathic arthritis constitute a homogeneous subgroup irrespective of the course of joint disease. (2005) (212)
- Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial. (2010) (211)
- Treating juvenile idiopathic arthritis to target: recommendations of an international task force (2018) (209)
- Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis. (2010) (202)
- EULAR recommendations for vaccination in paediatric patients with rheumatic diseases (2011) (202)
- Long‐term outcome and prognostic factors of juvenile dermatomyositis: A multinational, multicenter study of 490 patients (2010) (202)
- EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I: Overall methodology and clinical characterisation (2010) (198)
- Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis. (2003) (196)
- Pediatric Antiphospholipid Syndrome: Clinical and Immunologic Features of 121 Patients in an International Registry (2008) (193)
- Macrophage activation syndrome. (2002) (188)
- Comparison of clinical versus ultrasound-determined synovitis in juvenile idiopathic arthritis. (2009) (187)
- Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis (2016) (187)
- A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features. (2012) (185)
- Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritis. (1996) (184)
- ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study (2017) (181)
- Systemic sclerosis in childhood: clinical and immunologic features of 153 patients in an international database. (2006) (181)
- Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis: defining criteria based on the juvenile arthritis disease activity score. (2012) (173)
- The Pediatric Rheumatology European Society/American College of Rheumatology/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosis. (2007) (163)
- Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial (2016) (153)
- Assessment of damage in juvenile-onset systemic lupus erythematosus: a multicenter cohort study. (2003) (152)
- Juvenile Idiopathic Arthritis: Diagnosis and Treatment (2016) (152)
- A New Approach to Clinical Care of Juvenile Idiopathic Arthritis: The Juvenile Arthritis Multidimensional Assessment Report (2011) (152)
- Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine. (1996) (150)
- Antinuclear antibody-positive patients should be grouped as a separate category in the classification of juvenile idiopathic arthritis. (2011) (149)
- Consensus-based recommendations for the management of juvenile dermatomyositis (2016) (149)
- An International Consensus Survey of Diagnostic Criteria for Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis (2011) (141)
- Development and validation of a clinical index for assessment of long-term damage in juvenile idiopathic arthritis. (2005) (141)
- The provisional Paediatric Rheumatology International Trials Organisation/American College of Rheumatology/European League Against Rheumatism Disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation study. (2008) (140)
- Magnetic resonance imaging, ultrasonography, and conventional radiography in the assessment of bone erosions in juvenile idiopathic arthritis. (2008) (137)
- Proxy-reported health-related quality of life of patients with juvenile idiopathic arthritis: the Pediatric Rheumatology International Trials Organization multinational quality of life cohort study. (2007) (133)
- Early predictors of outcome in juvenile idiopathic arthritis. (2003) (132)
- Long-term health outcomes and quality of life in American and Italian inception cohorts of patients with juvenile rheumatoid arthritis. I. Outcome status. (1997) (129)
- A proposal for a pediatric version of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index based on the analysis of 1,015 patients with juvenile-onset systemic lupus erythematosus. (2006) (127)
- Nephrotic-range proteinuria, the major risk factor for early atherosclerosis in juvenile-onset systemic lupus erythematosus. (2000) (127)
- European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative. (2019) (127)
- Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative (2018) (126)
- Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease (2020) (126)
- Defining Criteria for Disease Activity States in Nonsystemic Juvenile Idiopathic Arthritis Based on a Three‐Variable Juvenile Arthritis Disease Activity Score (2014) (113)
- Development and validation of a preliminary definition of minimal disease activity in patients with juvenile idiopathic arthritis. (2008) (112)
- European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative (2017) (112)
- Evaluation of 21-Numbered Circle and 10-Centimeter Horizontal Line Visual Analog Scales for Physician and Parent Subjective Ratings in Juvenile Idiopathic Arthritis (2010) (112)
- Clinical outcome measures in juvenile idiopathic arthritis (2016) (109)
- Whole-body MRI in the assessment of disease activity in juvenile dermatomyositis (2013) (108)
- Correlation between conventional disease activity measures in juvenile chronic arthritis (1997) (106)
- Health-related quality of life in juvenile-onset systemic lupus erythematosus and its relationship to disease activity and damage. (2004) (105)
- The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis (2012) (104)
- Long-term health outcomes and quality of life in American and Italian inception cohorts of patients with juvenile rheumatoid arthritis. II. Early predictors of outcome. (1997) (104)
- Toward an understanding of the long-term outcome of juvenile idiopathic arthritis. (2004) (104)
- Performance of the preliminary definition of improvement in juvenile chronic arthritis patients treated with methotrexate (1998) (102)
- Prognostic factors for radiographic progression, radiographic damage, and disability in juvenile idiopathic arthritis. (2003) (102)
- Performance of Current Guidelines for Diagnosis of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis (2014) (98)
- Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index. (2009) (98)
- Ultrasound-detected synovial abnormalities are frequent in clinically inactive juvenile idiopathic arthritis, but do not predict a flare of synovitis (2012) (95)
- Effect of Biologic Therapy on Clinical and Laboratory Features of Macrophage Activation Syndrome Associated With Systemic Juvenile Idiopathic Arthritis (2018) (95)
- Development and validation of a new short and simple measure of physical function for juvenile idiopathic arthritis. (2007) (94)
- Advances and challenges in imaging in juvenile idiopathic arthritis (2012) (91)
- High prevalence of antiphospholipid antibodies in children with idiopathic cerebral ischemia. (1994) (90)
- Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study. (2019) (88)
- Marked and sustained improvement two years after autologous stem cell transplantation in a girl with systemic sclerosis. (1999) (85)
- Type I interferon pathway activation in COPA syndrome. (2017) (84)
- European consensus-based recommendations for the diagnosis and treatment of Kawasaki disease – the SHARE initiative (2018) (84)
- Performance of the new SLICC classification criteria in childhood systemic lupus erythematosus: a multicentre study. (2014) (84)
- Adapted versions of the Sharp/van der Heijde score are reliable and valid for assessment of radiographic progression in juvenile idiopathic arthritis. (2007) (83)
- The Pediatric Rheumatology International Trials Organization criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: prospective validation of the disease activity core set. (2005) (83)
- Antiphospholipid antibody syndrome in pediatric patients. (1997) (83)
- Evidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis (2015) (81)
- Level of agreement between children, parents, and physicians in rating pain intensity in juvenile idiopathic arthritis. (2006) (80)
- Outcome in juvenile onset systemic lupus erythematosus (2005) (80)
- The Paediatric Rheumatology International Trials Organisation provisional criteria for the evaluation of response to therapy in juvenile dermatomyositis (2010) (79)
- Macrophage migration inhibitory factor in patients with juvenile idiopathic arthritis. (2002) (78)
- The magnitude of early response to methotrexate therapy predicts long-term outcome of patients with juvenile idiopathic arthritis (2007) (78)
- Dynamic contrast-enhanced magnetic resonance imaging in the assessment of disease activity in patients with juvenile idiopathic arthritis. (2010) (77)
- Defining criteria for high disease activity in juvenile idiopathic arthritis based on the Juvenile Arthritis Disease Activity Score (2013) (77)
- European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative (2017) (76)
- Efficacy of folinic acid in reducing methotrexate toxicity in juvenile idiopathic arthritis. (1999) (75)
- 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative In (2017) (75)
- Radiologic progression in patients with juvenile chronic arthritis treated with methotrexate. (1998) (75)
- Relationship between Damage Accrual, Disease Flares and Cumulative Drug Therapies in Juvenile-Onset Systemic Lupus Erythematosus (2006) (75)
- Preliminary validation of clinical remission criteria using the OMERACT filter for select categories of juvenile idiopathic arthritis. (2006) (74)
- The Pediatric Rheumatology International Trials Organization/American College of Rheumatology provisional criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: prospective validation of the definition of improvement. (2006) (74)
- Parent and Child Acceptable Symptom State in Juvenile Idiopathic Arthritis (2012) (71)
- Anticardiolipin antibodies in pediatric systemic lupus erythematosus. (1994) (70)
- Cross-cultural adaptation and psychometric evaluation of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) in 54 languages across 52 countries: review of the general methodology (2018) (70)
- Intravenous iron therapy for severe anaemia in systemic-onset juvenile chronic arthritis (1994) (70)
- Seeking insights into the EPidemiology, treatment and Outcome of Childhood Arthritis through a multinational collaborative effort: Introduction of the EPOCA study (2012) (69)
- Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting (2018) (68)
- Assessing current outcomes of juvenile idiopathic arthritis: a cross-sectional study in a tertiary center sample. (2008) (67)
- Development of the autoinflammatory disease damage index (ADDI) (2016) (67)
- Review: Macrophage activation syndrome in juvenile systemic lupus erythematosus: an under-recognized complication? (2007) (67)
- Achievement of a State of Inactive Disease at Least Once in the First 5 Years Predicts Better Outcome of Patients with Polyarticular Juvenile Idiopathic Arthritis (2009) (67)
- European consensus-based recommendations for the diagnosis and treatment of rare paediatric vasculitides – the SHARE initiative (2018) (67)
- Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis (2016) (66)
- The Italian version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). (2001) (66)
- Neurological disorders, other than stroke, associated with antiphospholipid antibodies in childhood. (1996) (65)
- Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis (2019) (65)
- Preliminary evidence that etanercept may reduce radiographic progression in juvenile idiopathic arthritis. (2008) (65)
- Use of the Sharp and Larsen scoring methods in the assessment of radiographic progression in juvenile idiopathic arthritis. (2006) (65)
- Outcome and predicting factors of single and multiple intra-articular corticosteroid injections in children with juvenile idiopathic arthritis. (2011) (65)
- Methotrexate improves the health-related quality of life of children with juvenile idiopathic arthritis (2007) (64)
- European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome: the SHARE initiative (2017) (64)
- Development and preliminary validation of a paediatric-targeted MRI scoring system for the assessment of disease activity and damage in juvenile idiopathic arthritis (2010) (62)
- Outcome of primary antiphospholipid syndrome in childhood (2003) (62)
- The extended oligoarticular subtype is the best predictor of methotrexate efficacy in juvenile idiopathic arthritis. (1999) (62)
- Multi-antibody composition in lupus nephritis: isotype and antigen specificity make the difference. (2015) (62)
- Clinical features and correct diagnosis of macrophage activation syndrome (2015) (61)
- Methotrexate in juvenile idiopathic arthritis: answers and questions. (2000) (59)
- Toward a treat-to-target approach in the management of juvenile idiopathic arthritis. (2012) (59)
- Immune responses to the Escherichia coli dnaJ heat shock protein in juvenile rheumatoid arthritis and their correlation with disease activity. (1994) (59)
- Childhood multisystem inflammatory syndrome associated with COVID-19 (MIS-C): a diagnostic and treatment guidance from the Rheumatology Study Group of the Italian Society of Pediatrics (2021) (58)
- Efficacy and Adverse Events During Janus Kinase Inhibitor Treatment of SAVI Syndrome (2019) (58)
- Cytokines in juvenile rheumatoid arthritis. (1997) (57)
- Responsiveness of clinical measures in children with oligoarticular juvenile chronic arthritis. (1999) (57)
- Factors affecting the efficacy of intraarticular corticosteroid injection of knees in juvenile idiopathic arthritis. (2001) (56)
- Prevalence of anticardiolipin antibodies in juvenile chronic arthritis. (1991) (56)
- Vaccination in paediatric patients with auto-immune rheumatic diseases: a systemic literature review for the European League against Rheumatism evidence-based recommendations. (2011) (56)
- Predictors of poor response to methotrexate in polyarticular-course juvenile idiopathic arthritis: analysis of the PRINTO methotrexate trial (2010) (56)
- Self epitopes shared between human skeletal myosin and Streptococcus pyogenes M5 protein are targets of immune responses in active juvenile dermatomyositis. (2002) (55)
- Neutrophil Extracellular Traps Profiles in Patients with Incident Systemic Lupus Erythematosus and Lupus Nephritis (2020) (55)
- Methotrexate therapy may prevent the onset of uveitis in juvenile idiopathic arthritis. (2013) (54)
- Circulating levels of interleukin 1 beta and of interleukin 1 receptor antagonist in systemic juvenile chronic arthritis. (1995) (54)
- Dissecting the Heterogeneity of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis (2015) (54)
- Towards a role of ultrasound in children with juvenile idiopathic arthritis. (2013) (54)
- Developing outcome measures for paediatric rheumatic diseases. (2009) (54)
- Correlation between juvenile idiopathic arthritis activity and damage measures in early, advanced, and longstanding disease. (2006) (54)
- A longitudinal PRINTO study on growth and puberty in juvenile systemic lupus erythematosus (2011) (53)
- Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey (2021) (53)
- Efficacy of early anti-inflammatory treatment with high doses of intravenous anakinra with or without glucocorticoids in patients with severe COVID-19 pneumonia (2021) (53)
- Improving inflammatory arthritis management through tighter monitoring of patients and the use of innovative electronic tools (2016) (52)
- Frequency of autoantibodies in normal children. (1989) (51)
- Cyclosporine A in juvenile idiopathic arthritis. Results of the PRCSG/PRINTO phase IV post marketing surveillance study. (2006) (51)
- Therapeutic approaches in the treatment of juvenile dermatomyositis in patients with recent-onset disease and in those experiencing disease flare: an international multicenter PRINTO study. (2011) (49)
- Treatment of Takayasu's arteritis with tumor necrosis factor antagonists. (2008) (49)
- Consensus procedures and their role in pediatric rheumatology (2008) (49)
- Discordance between proxy-reported and observed assessment of functional ability of children with juvenile idiopathic arthritis. (2001) (49)
- IgA nephropathy and Henoch-Schonlein syndrome occurring in the same patient. (1996) (48)
- A reappraisal of intra-articular corticosteroid therapy in juvenile idiopathic arthritis. (2010) (48)
- Plasma levels after oral methotrexate in children with juvenile rheumatoid arthritis. (1993) (48)
- The time has come to include assessment of radiographic progression in juvenile idiopathic arthritis clinical trials. (2008) (47)
- Course of joint disease in patients with antinuclear antibody-positive juvenile idiopathic arthritis. (2005) (46)
- Comparison of clinical features and drug therapies among European and Latin American patients with juvenile dermatomyositis. (2011) (46)
- Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome (2017) (46)
- Temporomandibular Joint Involvement in Association With Quality of Life, Disability, and High Disease Activity in Juvenile Idiopathic Arthritis (2017) (46)
- Frequency of relapse after discontinuation of methotrexate therapy for clinical remission in juvenile rheumatoid arthritis. (1995) (46)
- Dramatic efficacy of cyclosporine A in macrophage activation syndrome. (2001) (46)
- Health-related quality of life of patients with juvenile dermatomyositis: results from the Pediatric Rheumatology International Trials Organisation multinational quality of life cohort study. (2009) (45)
- Ferritin to Erythrocyte Sedimentation Rate Ratio: Simple Measure to Identify Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis (2019) (45)
- Remission in juvenile idiopathic arthritis. (2006) (45)
- Responsiveness of outcome measures in juvenile chronic arthritis. Italian Pediatric Rheumatology Study Group. (1999) (44)
- Update on the pathogenesis and treatment of juvenile idiopathic arthritis (2017) (44)
- Relative responsiveness of condition specific and generic health status measures in juvenile idiopathic arthritis (2005) (43)
- Soluble tumour necrosis factor receptor levels reflect coagulation abnormalities in systemic juvenile chronic arthritis. (1997) (43)
- Factors Associated with Achievement of Inactive Disease in Children with Juvenile Idiopathic Arthritis Treated with Etanercept (2013) (43)
- Pulmonary function in childhood connective tissue diseases. (1992) (43)
- Intra-articular corticosteroids versus intra-articular corticosteroids plus methotrexate in oligoarticular juvenile idiopathic arthritis: a multicentre, prospective, randomised, open-label trial (2017) (42)
- Muscle Expression of Type I and Type II Interferons Is Increased in Juvenile Dermatomyositis and Related to Clinical and Histologic Features (2019) (42)
- A longitudinal analysis of physical functional disability over the course of juvenile idiopathic arthritis (2007) (42)
- Discordance between physician's and parent's global assessments in juvenile idiopathic arthritis. (2007) (42)
- Methotrexate as a possible trigger of macrophage activation syndrome in systemic juvenile idiopathic arthritis. (2001) (40)
- Development and Testing of Reduced Joint Counts in Juvenile Idiopathic Arthritis (2009) (40)
- Physicians' and parents' ratings of inactive disease are frequently discordant in juvenile idiopathic arthritis. (2007) (39)
- MRI versus conventional measures of disease activity and structural damage in evaluating treatment efficacy in juvenile idiopathic arthritis (2012) (38)
- IL-1 Inhibition in Systemic Juvenile Idiopathic Arthritis (2016) (37)
- Advances in biomarkers for paediatric rheumatic diseases (2015) (37)
- Validation of the Childhood Health Assessment Questionnaire in active juvenile systemic lupus erythematosus. (2008) (36)
- Macrophage migration inhibitory factor (MIF) and oligoarticular juvenile idiopathic arthritis (o-JIA): association of MIF promoter polymorphisms with response to intra-articular glucocorticoids. (2007) (36)
- Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept (2016) (36)
- Inactive disease and remission in childhood‐onset systemic lupus erythematosus (2012) (36)
- A new short and simple health-related quality of life measurement for paediatric rheumatic diseases: initial validation in juvenile idiopathic arthritis. (2010) (36)
- Oral versus intramuscular methotrexate in juvenile chronic arthritis. Italian Pediatric Rheumatology Study Group. (1998) (35)
- Delineating the Role of Multiple Intraarticular Corticosteroid Injections in the Management of Juvenile Idiopathic Arthritis in the Biologic Era (2013) (35)
- Anticardiolipin syndrome in childhood: a report of two cases. (1990) (35)
- Serum level of KL-6 as a marker of interstitial lung disease in patients with juvenile systemic sclerosis. (2004) (35)
- Chronic recurrent multifocal osteomyelitis with unusual features (1995) (34)
- 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis (2017) (33)
- Enhanced interleukin 1 and depressed interleukin 2 production in juvenile arthritis. (1986) (32)
- Methotrexate therapy in refractory pediatric onset systemic lupus erythematosus. (1998) (32)
- Predictors of Effectiveness of Anakinra in Systemic Juvenile Idiopathic Arthritis (2019) (32)
- Review: The Paediatric Rheumatology International Trials Organization (PRINTO) (2007) (31)
- Antiphospholipid syndrome in pediatrics. (2007) (31)
- Systemic lupus erythematosus with Jaccoud's arthropathy mimicking juvenile rheumatoid arthritis. (1987) (31)
- Establishing an Updated Core Domain Set for Studies in Juvenile Idiopathic Arthritis: A Report from the OMERACT 2018 JIA Workshop (2019) (30)
- Development of a consensus core dataset in juvenile dermatomyositis for clinical use to inform research (2017) (30)
- CACP syndrome: identification of five novel mutations and of the first case of UPD in the largest European cohort (2013) (29)
- Development and Initial Validation of a Radiographic Scoring System for the Hip in Juvenile Idiopathic Arthritis (2010) (29)
- Positive family history of psoriasis does not affect the clinical expression and course of juvenile idiopathic arthritis patients with oligoarthritis. (2003) (29)
- Functional ability and physical and psychosocial well-being of hypermobile schoolchildren. (2004) (28)
- Preliminary criteria for global flares in childhood‐onset systemic lupus erythematosus (2011) (28)
- Recurrent juvenile dermatomyositis and cutaneous necrotizing arteritis with molecular mimicry between streptococcal type 5 M protein and human skeletal myosin. (1992) (28)
- Development and initial validation of a composite disease activity score for systemic juvenile idiopathic arthritis. (2020) (28)
- Combination therapy with methotrexate and cyclosporine A in juvenile idiopathic arthritis. (2002) (28)
- Anti-DNA antibodies in the primary antiphospholipid syndrome. (1993) (27)
- Antiphospholipid antibody associated thrombosis in juvenile chronic arthritis. (1992) (27)
- Criteria to define response to therapy in paediatric rheumatic diseases (2011) (27)
- The conundrum of juvenile psoriatic arthritis. (2015) (27)
- HRCT and pulmonary function tests in monitoring of lung involvement in juvenile systemic sclerosis (2009) (27)
- Factors associated with response to methotrexate in systemic‐onset juvenile chronic arthritis (1994) (25)
- Failure of anti Interleukin-1 β monoclonal antibody in the treatment of recurrent pericarditis in two children (2020) (25)
- Disease activity and damage in juvenile idiopathic arthritis: methotrexate era versus biologic era (2019) (25)
- Responsiveness of clinical measures to flare of disease activity in juvenile idiopathic arthritis. (2005) (25)
- Defining criteria for disease activity states in juvenile idiopathic arthritis. (2016) (24)
- Clinical assessment in juvenile dermatomyositis (2006) (24)
- Development and initial validation of composite parent‐ and child‐centered disease assessment indices for juvenile idiopathic arthritis (2011) (24)
- IgG autoantibodies to complement C1q in pediatric-onset systemic lupus erythematosus. (1997) (24)
- Next generation sequencing panel in undifferentiated autoinflammatory diseases identify patients with colchicine-responder recurrent fevers. (2019) (23)
- Pulmonary function in children with systemic lupus erythematosus. (1996) (22)
- Methotrexate treatment may prevent uveitis onset in patients with juvenile idiopathic arthritis: experiences and subgroup analysis in a cohort with frequent methotrexate use. (2016) (22)
- Female Sex and Oligoarthritis Category Are Not Risk Factors for Uveitis in Italian Children with Juvenile Idiopathic Arthritis (2014) (22)
- Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease (2021) (22)
- Glucocorticoids in paediatric rheumatology. (2011) (22)
- In silico validation of the Autoinflammatory Disease Damage Index (2018) (21)
- The clinical significance of antiphospholipid antibodies. (1997) (21)
- Agreement between physicians and parents in rating functional ability of children with juvenile idiopathic arthritis (2007) (20)
- Delineating the Application of Ultrasound in Detecting Synovial Abnormalities of the Subtalar Joint in Juvenile Idiopathic Arthritis (2016) (20)
- Evaluation of response to methotrexate by a functional index in juvenile chronic arthritis (1995) (20)
- European consensus-based recommendations for the diagnosis and treatment of rare paediatric vasculitides - the SHARE initiative. (2020) (20)
- Unilateral destructive wrist synovitis in juvenile idiopathic arthritis. (2004) (19)
- Management of adult-onset Still’s disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts (2019) (19)
- Patients with juvenile idiopathic arthritis become adults: the role of transitional care. (2018) (19)
- A56: Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Tocilizumab (2014) (19)
- Wegener Granulomatosis in a Child: Cutaneous Findings as the Presenting Signs (1999) (19)
- Measuring Disease Damage and Its Severity in Childhood‐Onset Systemic Lupus Erythematosus (2018) (18)
- Performance of Birmingham Vasculitis Activity Score and disease extent index in childhood vasculitides. (2012) (18)
- Optimisation of disease assessments in juvenile idiopathic arthritis. (2014) (18)
- Novel automated system for magnetic resonance imaging quantification of the inflamed synovial membrane volume in patients with juvenile idiopathic arthritis (2012) (18)
- Possible discontinuation of therapies after clinical remission in juvenile idiopathic arthritis. (2013) (18)
- The EULAR Outcome Measures Library: development and an example from a systematic review for systemic lupus erythematous instruments. (2015) (17)
- A Phase II Study to Evaluate Dosing and Preliminary Safety and Efficacy of Canakinumab in Systemic Juvenile Idiopathic Arthritis With Active Systemic Features (2012) (17)
- Antiphospholipid antibodies in paediatrics (1994) (17)
- Frequency and complications of chronic iridocyclitis in ANA-positive pauciarticular juvenile chronic arthritis (2004) (17)
- Glucocorticoids in Juvenile Idiopathic Arthritis (2014) (17)
- Autoantibodies in juvenile dermatomyositis. (1990) (17)
- Mobilization and selection of peripheral blood hematopoietic progenitors in children with systemic sclerosis. (1999) (17)
- Methotrexate hepatotoxic effects in children with juvenile rheumatoid arthritis. (1991) (16)
- FRI0328 Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (SJIA): 2-year data from tender, a phase 3 clinical trial (2013) (16)
- Unraveling the Phenotypic Variability of Juvenile Idiopathic Arthritis across Races or Geographic Areas — Key to Understanding Etiology and Genetic Factors? (2016) (16)
- Multisystem Inflammatory Syndrome in Children: Unique Disease or Part of the Kawasaki Disease Spectrum? (2021) (16)
- Marked and sustained improvement 2 years after autologous stem cell transplantation in a girl with systemic sclerosis. (1999) (16)
- Development and Testing of a Hybrid Measure of Muscle Strength in Juvenile Dermatomyositis for Use in Routine Care (2018) (15)
- Next generation sequencing panel in undifferentiated autoinflammatory diseases identifies patients with colchicine-responder recurrent fevers. (2019) (15)
- Inter-observer agreement of the physician's global assessment of disease activity in children with juvenile idiopathic arthritis. (2005) (15)
- Current Research in Outcome Measures for Pediatric Rheumatic and Autoinflammatory Diseases (2016) (15)
- Development of an internationally agreed minimal dataset for juvenile dermatomyositis (JDM) for clinical and research use (2015) (15)
- Weighting improves the information provided by joint counts on the severity of arthritis and its impact on patients' well-being in juvenile idiopathic arthritis. (2006) (14)
- Elevated IgA anti-gliadin antibodies in juvenile chronic arthritis. (1991) (14)
- The PRINTO evidence-based proposal for glucocorticoids tapering/discontinuation in new onset juvenile dermatomyositis patients (2019) (14)
- Ultrasound changes in synovial abnormalities induced by treatment in juvenile idiopathic arthritis. (2018) (14)
- Definition and Validation of the American College of Rheumatology 2021 Juvenile Arthritis Disease Activity Score Cutoffs for Disease Activity States in Juvenile Idiopathic Arthritis (2021) (14)
- Therapeutic approaches for the treatment of renal disease in juvenile systemic lupus erythematosus: an international multicentre PRINTO study (2012) (14)
- The antiphospholipid syndrome in childhood. (1996) (14)
- Aortic valve regurgitation as the presenting sign of Takayasu arteritis (1999) (14)
- Henoch-Schönlein syndrome and selective IgA deficiency. (1985) (13)
- Neutrophil Extracellular Traps in the Autoimmunity Context (2021) (13)
- Severe retinopathy in systemic lupus erythematosus associated with IgG anticardiolipin antibodies (1993) (13)
- Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis treated with tocilizumab (2014) (13)
- American College of Rheumatology Provisional Criteria for Global Flares in Childhood‐Onset Systemic Lupus Erythematosus (2018) (13)
- The European network for care of children with paediatric rheumatic diseases: care across borders. (2019) (13)
- Toward the Development of New Diagnostic Criteria for Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis (2012) (13)
- Introducing new tools for assessment of parent- and child-reported outcomes in paediatric rheumatology practice: a work in progress. (2013) (13)
- Open issues in the assessment and management of pain in juvenile idiopathic arthritis. (2017) (13)
- Paediatric rheumatology: Juvenile idiopathic arthritis—are biologic agents effective for pain? (2013) (13)
- Is Macrophage Activation Syndrome in Kawasaki Disease Underrecognized? (2020) (12)
- Treating Juvenile Idiopathic Arthritis According to JADAS- Based Targets (2014) (12)
- Timely Recognition and Early Multi-Step Antinflammatory Therapy May Prevent ICU Admission of Patients With MIS-C: Proposal for a Severity Score (2021) (12)
- Does removal of aids/devices and help make a difference in the Childhood Health Assessment Questionnaire disability index? (2009) (12)
- Neutrophil Extracellular Traps-DNase Balance and Autoimmunity (2021) (11)
- Recent advances in quantitative assessment of juvenile idiopathic arthritis (2012) (11)
- Impact of involvement of individual joint groups on subdimensions of functional ability scales in juvenile idiopathic arthritis (2008) (11)
- EULAR/PRES recommendations for vaccination of paediatric patients with autoimmune inflammatory rheumatic diseases: update 2021 (2022) (11)
- Defining Kawasaki Disease and Pediatric Multi-Inflammatory Syndrome During SARS-CoV-2 Epidemic in Italy: Results From A National, Multicenter Survey. (2020) (11)
- Interferon-gamma (IFNy) in macrophage activation syndrome (MAS) associated with systemic juvenile idiopathic arthritis (sJIA). High levels in patients and a role in a murine mas model (2014) (10)
- A Meta‐Analysis to Estimate the Placebo Effect in Randomized Controlled Trials in Juvenile Idiopathic Arthritis (2016) (10)
- American College of Rheumatology Provisional Criteria for Clinically Relevant Improvement in Children and Adolescents With Childhood‐Onset Systemic Lupus Erythematosus (2019) (10)
- Antiphospholipid syndrome. (2005) (10)
- Kawasaki disease or Kawasaki syndrome? (2020) (10)
- It Is Worth Including Assessment of Disease Activity State in Juvenile Arthritis Clinical Trials (2013) (10)
- Uncommon causes of liver disease in juvenile systemic lupus erythematosus. (2001) (10)
- PReS-FINAL-2184: A randomized trial in new onset juvenile dermatomyositis: prednisone versus prednisone plus cyclosporine versus prednisone plus methotrexate (2013) (9)
- A novel assessment tool for clinical care of patients with autoinflammatory disease: juvenile autoinflammatory disease multidimensional assessment report. (2016) (9)
- OP0059 A Randomized Trial in New Onset Juvenile Dermatomyositis: Prednisone Versus Prednisone Plus Cyclosporine Versus Prednisone Plus Methotrexate (2013) (9)
- Development of new classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis (2014) (9)
- Visceral leishmaniasis as a cause of unexplained fever and cytopenia in systemic lupus erythematosus (2002) (9)
- Evidence for Updating the Core Domain Set of Outcome Measures for Juvenile Idiopathic Arthritis: Report from a Special Interest Group at OMERACT 2016 (2017) (9)
- Development and validation of a preliminary definition of minimal disease activity in juvenile idiopathic arthritis (2008) (9)
- Incidence rate of MIS‐C in paediatrics: A good reason to vaccinate children against SARS‐CoV‐2 (2021) (9)
- Transitional care of young people with juvenile idiopathic arthritis in Italy: results of a Delphi consensus survey. (2019) (8)
- Recent therapeutic advances in juvenile idiopathic arthritis. (2017) (8)
- Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study (2020) (8)
- Comparison Between Clinical and Ultrasound Assessment of the Ankle Region in Children With Juvenile Idiopathic Arthritis (2020) (8)
- Handbook of Juvenile Idiopathic Arthritis (2015) (8)
- IgG subclass serum levels in juvenile chronic arthritis. (1986) (8)
- Frequency of Radiographic Damage and Progression in Individual Joints in Children With Juvenile Idiopathic Arthritis (2014) (8)
- Macrophage activation syndrome (MAS) in juvenile systemic lupus erythematosus (JSLE): an underrecognized complication? (2008) (8)
- Antiphospholipid antibodies in children with idiopathic cerebral ischaemia (1994) (8)
- Recommendations for collaborative paediatric research including biobanking in Europe: a Single Hub and Access point for paediatric Rheumatology in Europe (SHARE) initiative (2017) (8)
- Failure of first anti-TNF agent in Takayasu's arteritis: to switch or to swap? (2021) (7)
- Preliminary classification criteria for systemic sclerosis in children. (2005) (7)
- Development and validation of a composite disease activity score for measurement of muscle and skin involvement in juvenile dermatomyositis. (2019) (7)
- Should children and adolescents with systemic lupus erythematosus be given statin therapy to prevent early atherosclerosis? (2012) (7)
- Developing a provisional, international Minimal Dataset for Juvenile Dermatomyositis: for use in clinical practice to inform research (2014) (7)
- Wegener's granulomatosis presenting with life-threatening pulmonary hemorrhage in a boy with type 1 diabetes. (1999) (7)
- Macrophage activation syndrome in pediatrics (2020) (7)
- A prediction rule for lack of achievement of inactive disease with methotrexate as the sole disease-modifying antirheumatic therapy in juvenile idiopathic arthritis (2019) (7)
- The invisible part of the iceberg: qualitative aspects of childhood vasculitis. (2014) (7)
- Information technology in paediatric rheumatology. (2016) (6)
- Calcinosis as the presenting sign of juvenile dermatomyositis in a 14-month-old boy. (1987) (6)
- Efficacy and Safety of Tocilizumab in Patients with Systemic Juvenile Idiopathic Arthritis: 2-Year Data From a Phase III Clinical Trial (2011) (6)
- Successful treatment of refractory hyperferritinemic syndromes with canakinumab: a report of two cases (2020) (6)
- Hypergammaglobulinemic purpura in childhood. Report of two cases and review of the literature. (1988) (6)
- Disease activity, overweight, physical activity and screen time in a cohort of patients with juvenile idiopathic arthritis. (2018) (6)
- High levels of interferon-gamma (IFNγ) in macrophage activation syndrome (MAS) and CXCL9 levels as a biomarker for IFNγ production in MAS (2015) (6)
- Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part one (2017) (6)
- Recurrent macrophage activation syndrome in spondyloarthritis and monoallelic missense mutations in PRF1: a description of one paediatric case. (2016) (6)
- [The Schönlein-Henoch syndrome with severe multisystemic involvement]. (1993) (6)
- Health related quality of life measure in systemic pediatric rheumatic diseases and its translation to different languages: an international collaboration (2014) (6)
- Tocilizumab may slow radiographic progression in patients with systemic or polyarticular-course juvenile idiopathic arthritis: post hoc radiographic analysis from two randomized controlled trials (2020) (6)
- Thrombotic Microangiopathy Associated With Macrophage Activation Syndrome: A Multinational Study of 23 Patients. (2021) (5)
- Transient remission of systemic manifestations following intraarticular triamcinolone hexacetonide injection in a boy with systemic juvenile idiopathic arthritis. (2002) (5)
- Frequency and clinical significance of anti-RNP antibodies in Italian SLE patients. (1994) (5)
- Superior vena cava thrombosis in a child with antiphospholipid syndrome. (1992) (5)
- Recurrence of previous chilblain lesions during the second wave of COVID‐19: can we still doubt the correlation with SARS‐CoV‐2? (2021) (5)
- Novel biomarkers for prediction of outcome and therapeutic response in juvenile idiopathic arthritis (2021) (5)
- Evaluation of Biopsychosocial Aspects of Patients with Juvenile Autoinflammatory Disease: A Qualitative Study (2014) (5)
- Acute pain management in children: a survey of Italian pediatricians (2019) (5)
- Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis. (2020) (5)
- Sensitivity and specificity of current diagnostic guidelines in children with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis (2011) (5)
- Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still’s disease (2022) (4)
- Musculoskeletal manifestations of childhood cancer and differential diagnosis with juvenile idiopathic arthritis (ONCOREUM): a multicentre, cross-sectional study (2021) (4)
- [Multiple cartilaginous exostoses]. (1953) (4)
- Innovative Research Design to Meet the Challenges of Clinical Trials for Juvenile Dermatomyositis (2018) (4)
- Filling the Gap: Toward a Disease Activity Tool for Systemic Juvenile Idiopathic Arthritis (2018) (4)
- Underlying CTLA4 Deficiency in a Patient With Juvenile Idiopathic Arthritis and Autoimmune Lymphoproliferative Syndrome Features Successfully Treated With Abatacept—A Case Report (2021) (4)
- Expanding the clinical and neuroimaging features of post-varicella arteriopathy of childhood (2021) (4)
- Agreement Among Musculoskeletal Pediatric Specialists in the Assessment of Radiographic Joint Damage in Juvenile Idiopathic Arthritis (2014) (4)
- Growth and Puberty in Juvenile Dermatomyositis: A Longitudinal Cohort Study (2020) (4)
- Development and initial validation of the parent acceptable symptom state in juvenile idiopathic arthritis (JIA) (2008) (4)
- Predictive Value of Magnetic Resonance Imaging in Patients With Juvenile Idiopathic Arthritis in Clinical Remission (2021) (4)
- Urinary microscopy in the diagnosis of haematuria in schönlein-henoch purpura (1986) (4)
- [Transient stenosing ureteritis in childhood. A rare complication of rheumatoid purpura]. (1985) (4)
- SAPHO syndrome and pulmonary disease. (1996) (4)
- Anuria due to bilateral cystine urolithiasis in an infant. (1986) (3)
- Periostin gene variants are associated with disease course and severity in juvenile idiopathic arthritis. (2014) (3)
- Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part two (2017) (3)
- Focal segmental glomerulosclerosis and Charcot-Marie-Tooth disease. (1985) (3)
- Uncommon syndromes and treatment manifestations of malignancy: Case 1. Unusual association of lupus and sarcoma. (2003) (3)
- Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part two (2017) (3)
- CANAKINUMAB IN SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: REAL-LIFE DATA FROM A RETROSPECTIVE ITALIAN COHORT. (2021) (3)
- Paediatric rheumatic disease: What is the best definition of clinical remission in JIA? (2017) (3)
- Efficacy, Immunogenicity and Safety of Vaccination in Pediatric Patients With Autoimmune Inflammatory Rheumatic Diseases (pedAIIRD): A Systematic Literature Review for the 2021 Update of the EULAR/PRES Recommendations (2022) (3)
- The Effect of Morning Stiffness Duration on the Definition of Clinically Inactive Disease in Juvenile Idiopathic Arthritis (2020) (3)
- Management of Patients with Juvenile Idiopathic Arthritis (2016) (3)
- Unusual case of childhood dermatomyositis. (1985) (3)
- FRI0336 Comparison of construct validity of two functional ability measures in children with juvenile dermatomyositis (2013) (3)
- Agreement between multi-dimensional and renal-specific response criteria in patients with juvenile systemic lupus erythematosus and renal disease. (2010) (3)
- Macrophage Activation Syndrome in Childhood Rheumatic Diseases (2007) (3)
- THU0569 MANAGEMENT OF ADULT-ONSET STILL’S DISEASE (AOSD) WITH IL-1 INHIBITORS: EVIDENCE- AND CONSENSUS-BASED STATEMENTS BY A PANEL OF ITALIAN EXPERTS (2019) (3)
- Development and initial validation of a new functional ability tool for juvenile dermatomyositis (2011) (3)
- The challenge of early diagnosis of autoimmune lymphoproliferative syndrome in children with suspected autoinflammatory/autoimmune disorders. (2021) (3)
- A11: Assessment of Radiographic Progression in Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis Treated With Tocilizumab: 2‐Year Data From CHERISH (2014) (3)
- Systemic Lupus Erythematosus (2012) (3)
- Development of New Juvenile Arthritis Disease Activity Score Cut-Offs for Oligoarthritis and RF-Negative Polyarthritis from a Large Multinational Cohort of Children with Juvenile Idiopathic Arthritis (2017) (2)
- [Epitriquetrum; critical view of the report by E. de Cuveland on a "not yet described" accessory carpal bone of the previously mentioned name]. (1956) (2)
- Register for pediatric patients with antiphospholipid syndrome (2007) (2)
- Preliminary validation of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) in 403 clinic patients (2008) (2)
- FRI0271 Final Evidence-Based Recommendations for Diagnosis and Treatment of Paediatric Vasculitides (2015) (2)
- LB0004 EFFICACY AND SAFETY OF SECUKINUMAB IN ENTHESITIS-RELATED ARTHRITIS AND JUVENILE PSORIATIC ARTHRITIS: PRIMARY RESULTS FROM A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, TREATMENT WITHDRAWAL, PHASE 3 STUDY (JUNIPERA) (2021) (2)
- Variation of serum IgG subclass concentrations with disease activity in juvenile chronic arthritis. (1989) (2)
- Health related quality of life of patients with juvenile dermatomyositis. The printo multinational quality of life cohort study. (2006) (2)
- [Changes of roentgenologic septum pellucidum]. (1952) (2)
- Intravenous immunoglobulin for corticosteroid-resistant intestinal Henoch-Schönlein purpura: worth a controlled trial against corticosteroids? (2020) (2)
- Frequency of remission in children with juvenile idiopathic arthritis treated with etanercept: Methodological considerations and preliminary results from a single center (2013) (2)
- Antiphospholipid antibody syndrome as a cause of venous thrombosis in childhood. (1994) (2)
- Critical role of STIR MRI in early detection of post-streptococcal periostitis with dysproteinaemia (Goldbloom's syndrome). (2017) (2)
- Time of onset of iridocyclitis (IC) in children with juvenile idiopathic arthritis (JIA) (2008) (2)
- [Accessory nuclei at basal terminal part of big toe]. (1956) (2)
- Development and Testing of Reduced Versions of the Manual Muscle Test-8 in Juvenile Dermatomyositis (2020) (2)
- FRI0565 A MULTINATIONAL STUDY OF THROMBOTIC MICROANGIOPATHY IN MACROPHAGE ACTIVATION SYNDROME: A DREADFUL CONDITION WHICH IS LIKELY UNDER-RECOGNIZED (2019) (2)
- Comparison of treatments and outcomes of children with juvenile dermatomyositis followed at two European tertiary care referral centers. (2021) (2)
- Multifactorial Posterior Reversible Encephalopathy Syndrome in Children: Clinical, Laboratory, and Neuroimaging Findings (2020) (2)
- OP0004 Predictors of achievement of inactive disease in children with juvenile idiopathic arthritis treated with etanercept (2013) (2)
- Second Wave Antibodies in Autoimmune Renal Diseases: The Case of Lupus Nephritis. (2021) (2)
- Cardiovascular Manifestations in Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19 According to Age (2022) (2)
- A systematic literature review informing the consensus statement on efficacy and safety of pharmacological treatment with interleukin-6 pathway inhibition with biological DMARDs in immune-mediated inflammatory diseases (2022) (2)
- Determinants of Discordance Between Criteria for Inactive Disease and Low Disease Activity in Juvenile Idiopathic Arthritis (2020) (2)
- A66: Assessment of Radiographic Progression in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Tocilizumab: 2‐Year Results From the TENDER Trial (2014) (2)
- Is Anti-NXP2 Autoantibody a Risk Factor for Calcinosis and Poor Outcome in Juvenile Dermatomyositis Patients? Case Series (2022) (2)
- Multiple inhibitors of mitogen-induced proliferation of normal lymphocytes in juvenile chronic arthritis sera. (1990) (2)
- Musculoskeletal ultrasound versus magnetic resonance in supporting clinical management of juvenile idiopathic arthritis (2014) (2)
- Evaluation of musculoskeletal complaints in children (2011) (2)
- MRI and ultrasound versus conventional measures of disease activity and structural damage in evaluating treatment efficacy in JIA. Do these imaging techniques have an additional value? (2011) (2)
- A multinational study of the epidemiology, treatment and outcome of childhood arthritis (epoca study): preliminary data from 6,940 patients (2014) (2)
- Pediatric Antiphospholipid Syndrome: from Pathogenesis to Clinical Management (2021) (2)
- [TMJ in subjects with juvenile rheumatoid arthritis: functional and cephalometric analysis]. (1991) (2)
- [Pathogenesis of the so-called Bechterew disease]. (1956) (2)
- Prevalence ofanticardiolipin antibodies injuvenile chronic arthritis (1991) (2)
- [Ischemic necrosis of femoral condyles in systemic lupus erythematosus]. (1989) (2)
- A prediction rule for polyarticular extension in oligoarticular-onset juvenile idiopathic arthritis. (2021) (2)
- The Italian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) (2018) (2)
- PReS-FINAL-2012: Introducing a new approach to clinical care of juvenile dermatomyositis: the juvenile dermatomyositis multidimensional assessment report (2013) (2)
- Chapter 7 – Juvenile Idiopathic Arthritis (2017) (2)
- Are Kawasaki Disease and Pediatric Multi-Inflammatory Syndrome Two Distinct Entities? Results from a Multicenter Survey During SARS-CoV-2 Epidemic in Italy (2020) (2)
- Does ultrasound agree with parent's perception of joint disease in juvenile idiopathic arthritis? (2014) (1)
- Development and validation of juvenile autoinflammatory disease multidimensional assessment report (JAIMAR) (2014) (1)
- Intra-articular venous malformations of the knee: a diagnostic challenge (2021) (1)
- Do parent's global rating of well-being and disease activity of children with juvenile idiopathic arthritis yield different information? (2008) (1)
- FRI0547 DEVELOPMENT AND INITIAL VALIDATION OF THE SYSTEMIC JADAS, A NEW COMPOSITE DISEASE ACTIVITY SCORE FOR SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (2019) (1)
- Response to: ‘MS score in systemic juvenile idiopathic arthritis: suitable for routine use?’ by Chi et al (2019) (1)
- Efficacy and Adverse Events During Janus Kinase Inhibitor Treatment of SAVI Syndrome (2019) (1)
- Criteria for Cytokine Storm Syndromes (2019) (1)
- [Changes in the production of IgM in response to pokeweed mitogen in juvenile rheumatoid arthritis. Correlations with disease activity]. (1990) (1)
- Criteria for Cytokine Storm Syndromes (2019) (1)
- Correction to: The Italian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) (2018) (1)
- PReS-FINAL-2011: Preliminary validation of a new hybrid measure of muscle strength for juvenile dermatomyositis (2013) (1)
- 289. Assessment of Radiographic Progression in Patients with Systemic Juvenile Idiopathic Arthritis Treated with Tocilizumab: 2-Year Results from the Tender Trial (2014) (1)
- [Postoperative ostitis pubis; periostitis of the pu bic bone]. (1954) (1)
- [Roentgenogram of proximal third of the tibia]. (1955) (1)
- SHARE – workpackage 5: development of best practices of diagnosis and treatment for paediatric rheumatic diseases throughout Europe (2014) (1)
- A controlled trial of intra-articular corticosteroids with or without methotrexate in oligoarticular juvenile idiopathic arthritis (2014) (1)
- The controversial role of wellbeing assessment in juvenile idiopathic arthritis (2020) (1)
- PReS-FINAL-2132: Defining criteria for high disease activity in juvenile idiopathic arthritis: definition and validation of juvenile arthritis disease activity score cutoffs (2013) (1)
- Towards development of treat to target (T2T) in childhood-onset systemic lupus erythematosus: PReS-endorsed overarching principles and points-to-consider from an international task force. (2023) (1)
- Response to: ‘Comparison of MS score and HScore for the diagnosis of adult-onset Still’s disease associated macrophage activation syndrome’ by Zhang et al (2020) (1)
- Sensitivity and specificity of current diagnostic guidelines in children with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis (2011) (1)
- [Extracranial subperiosteal epidermoid cysts of the frontal bone]. (1957) (1)
- Chronic intoxication by ethane-1-hydroxy-1,1-diphosphonate (EHDP) in a child with myositis ossificans progressiva (2005) (1)
- systemic-onset juvenile chronic arthritis erythropoietin production in the anemia associated with Defective iron supply for erythropoiesis and adequate endogenous (2009) (1)
- Update on Outcome Measures for Pediatric Systemic Lupus Erythematosus (2020) (1)
- Functional and prognostic significance of the-173 polymorphism of the macrophage migration inhibitory factor (MIF) gene in systemic JIA. (2002) (1)
- Proposal for the development of an international minimal data collection for juvenile dermatomyositis (JDM) (2011) (1)
- Treating to target of minimal disease activity and normal function in polyarticular juvenile idiopathic arthritis with adalimumab: analysis from a phase 3 clinical trial (2014) (1)
- Long-term follow-up of systemic onset juvenile idiopathic arthritis patients treated with Anakinra (2011) (1)
- Evaluation of musculoskeletal complaints in children: Clinical evaluation (2014) (1)
- Principles of management of juvenile idiopathic arthritis (2013) (1)
- A30: Assessment of Construct and Discriminative Validity of the 3‐Variable JADAS in Relation of Parent‐Reported Outcomes (2014) (1)
- A meta-analysis to estimate the “real” placebo effect in juvenile idiopathic arthritis (JIA) trials (2011) (1)
- OP0181 Treating to Target of Minimal Disease Activity and Normal Function in Polyarticular Juvenile Idiopathic Arthritis with Adalimumab: Analysis from A Phase 3 Clinical Trial (2014) (1)
- SP0102 Toward new diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis (2013) (1)
- Use of the JADAS criteria to assess efficacy of canakinumab in patients with SJIA – an analysis of 12-week pooled data (2014) (1)
- OP0062 The Addition of One or More Biologics to Methotrexate in Children with Juvenile Idiopathic Arthritis Increases the Incidence of Infections and Serious Adverse Events. The 5882 Pharmachild Cohort (2015) (1)
- MRI and ultrasound versus conventional measures of disease activity and structural damage in evaluating treatment efficacy in JIA. Do these imaging techniques have an additional value? (2011) (1)
- Maintenance of efficacy of canakinumab in SJIA at the individual patient level in a 12-week pooled dataset (2014) (1)
- Is it worth including subtalar joint in ultrasound ankle assessment of patients with juvenile idiopathic arthritis? (2014) (1)
- Juvenile idiopathic arthritis: will etanercept be an improvement over current therapies? (2000) (1)
- The JADAS: A Simple and Reliable Tool for the Measurement of Disease Activity in Juvenile Idiopathic Arthritis - (2014) (1)
- Final validation of a new composite disease activity score for juvenile idiopathic arthritis: the Juvenile Arthritis Disease Activity Score (JADAS) (2008) (1)
- Osteochondrolysis dissecans am Condylus fibularis femoris (1951) (1)
- Correction to: Management of adult-onset Still’s disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts (2020) (1)
- THU0473-HPR Living with childhood vasculitis; a qualitative study (2013) (1)
- THU0515 PAIN IS THE MAIN DETERMINANT OF WELL-BEING IN OLIGO- AND POLYARTICULAR JIA: EVIDENCE FROM THE PHARMACHILD REGISTRY (2019) (1)
- Medicine and humanism in the time of COVID-19. Ethical choices (2020) (1)
- General treatment aspects (2016) (1)
- [Osteochondritis dissecans of the carpal scaphoid]. (1955) (1)
- [Epiphysial necrosis of the spinous process of a lumbar vertebra]. (1954) (1)
- Jejunoscopies and ileoscopies in children. (1987) (1)
- Response to ‘Application of MS score in macrophage activation syndrome patients associated with adult onset Still’s disease’ by Wang et al (2019) (1)
- SAT0489 CLINICAL COURSE AND THERAPY RESPONSE IN TAKAYASU ARTERITIS: COMPARISION BETWEEN CHILDHOOD AND ADULT ONSET (2020) (1)
- Information technology in rheumatology. (2016) (1)
- THU0508 Safety and Efficacy of Tocilizumab in Patients with Systemic Juvenile Idiopathic Arthritis: 5-Year Data from Tender, A Phase 3 Clinical Trial (2015) (1)
- The diagnostic role of hyperferritinemia in a tertiary care pediatric rheumatology setting (2008) (1)
- AB0966 Pigmented Villonodular Synovitis: Not Only Synovectomy (2015) (1)
- Adalimumab-Induced Clinical Remission in Refractory and Long- Standing Systemic Juvenile Idiopathic Arthritis: Case Report (2014) (1)
- [History and clarification of the Tietze syndrome]. (1955) (1)
- SAT0506 Towards the Development of an Ultrasound Composite Disease Activity Score for Juvenile Idiopathic Arthritis (2015) (1)
- FRI0568 THE USE OF NEXT GENERATION SEQUENCING PANEL IN UNDIFFERENTIATED AUTOINFLAMMATORY DISEASES IDENTIFY A SEPARATE SUBSET OF COLCHICINE-RESPONDER RECURRENT FEVERS DISTINCT FROM PFAPA SYNDROME (2019) (1)
- Standardized nailfold capillaroscopy in children with rheumatic diseases: a worldwide study (2022) (1)
- Complications of severe acute respiratory syndrome coronavirus 2 infection in children (2022) (1)
- Neonatal lupus erythematosus in dizygotic twins with anti-RNP antibodies. (2021) (1)
- Consequences and complications (2016) (1)
- Extracellular vesicle‐derived microRNAs as potential biomarkers in oligoarticular juvenile idiopathic arthritis patients: methodological challenges and new perspectives (2022) (1)
- Macrophage activation syndrome is hemophagocytic lymphohistiocytosis - Need for the right terminology [2] (multiple letters) (2002) (1)
- Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update (2022) (1)
- THU0501 EARLY DIAGNOSIS OF THE AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME (ALPS) IN PATIENTS WITH UNDEFINED AUTOINFLAMMATORY OR AUTOIMMUNE DISORDERS: THE PRACTICAL ROLE OF A FLOW CYTOMETRY PANEL (2020) (1)
- Development and initial validation of the ONCOREUM score to differentiate childhood cancer with arthropathy from juvenile idiopathic arthritis. (2022) (1)
- Childhood multisystem inflammatory syndrome associated with COVID‐19 (MIS‐C): Distinct from Kawasaki disease or part of the same spectrum? (2022) (1)
- [Not Available]. (1948) (0)
- Experience with the use of mycophenolate mofetil in juvenile idiopathic inflammatory myopathies. (2022) (0)
- Biologic drugs in juvenile systemic lupus erythematosus (2007) (0)
- AB1020 Evaluation of the Disease Course of Italian Children with Juvenile Idiopathic Arthritis Treated with Etanercept: Preliminary Results in 1019 Patients (2015) (0)
- [Roentgenography of arteria lusoria]. (1950) (0)
- [Rare anomalous ossification of the proximal phalanges of the toes (conic epiphyses)]. (1952) (0)
- PReS-FINAL-2345: Frequency of radiographic damage and progression in individual joints in children with juvenile idiopathic arthritis (2013) (0)
- Evaluation of the power of six clustering features in identifying a homogeneous disease subset in juvenile idiopathic arthritis (JIA) (2008) (0)
- Is the parent global assessment a reliable quality of life measure in juvenile idiopathic arthritis? (2022) (0)
- FRI0330 Development of cut-off values for high disease activity in juvenile idiopathic arthritis based on the juvenile arthritis disease activity score (JADAS) (2013) (0)
- The Journal of Rheumatology Neutrophil Extracellular Traps (NETs) profiles in patients with incident SLE and (2019) (0)
- Paediatric rheumatology Analysis of arthritis flares after achievement of inactive disease with methotrexate monotherapy in juvenile idiopathic arthritis (2021) (0)
- Towards Defining Clinical Remission in Juvenile Systemic Lupus Erythematosus (jSLE) (2011) (0)
- Validity and Reliability of Four Parent/Patient–Reported Outcome Measures for Juvenile Idiopathic Arthritis Remote Monitoring (2022) (0)
- PReS-FINAL-2143: Treat-to-target strategy in juvenile idiopathic arthritis: experience in 175 newly-diagnosed patients (2013) (0)
- Agreement between objective and subjective definitions of inactive disease, remission and minimal disease activity in juvenile idiopathic arthritis (2011) (0)
- SHARE – workpackage 5: evidence-based recommendations for diagnosis and treatment of kawasaki disease and henoch schönlein purpura (2014) (0)
- Looking for the best strategy to treat children with new onset juvenile idiopathic arthritis: presentation of the “comparison of STep-up and step-down therapeutic strategies in childhood ARthritiS” (STARS) trial (2022) (0)
- OP0293 USE OF WHOLE-BODY MAGNETIC RESONANCE TO IDENTIFY POTENTIAL DIAGNOSTIC CLUES IN CHILDREN WITH FEVER OF UNKNOWN ORIGIN (FUO) (2020) (0)
- [Vascular channels in phalanges]. (1953) (0)
- Is it worth allowing the presence of morning stiffness in the definition of inactive disease in juvenile idiopathic arthritis? (2014) (0)
- [On the compacta type of the so-called osteoid osteoma Jaffe or the cortical osteoma Moberg]. (1956) (0)
- [Syphilitic focus in cranial bone]. (1956) (0)
- Sleep and Sleep Complaints in Juvenile Fibromyalgia Syndrome. (2023) (0)
- Does incorporation of aids/devices and help, make a difference in the childhood health assessment questionnaire disability index? Analysis from the printo juvenile idiopathic arthritis database (2008) (0)
- Children with juvenile idiopathic arthritis currently followed in a tertiary care setting have a better psychosocial well-being than healthy peers (2011) (0)
- PReS-FINAL-2134: Assessment of radiographic progression in patients (pts) with systemic juvenile idiopathic arthritis (sjia) treated with tocilizumab (TCZ): 2-year results from the tender trial (2013) (0)
- [Not Available]. (1954) (0)
- Arthritis Predicts Better Outcome of Patients with Polyarticular Juvenile Idiopathic Achievement of a State of Inactive Disease at Least Once in the First 5 Years (2009) (0)
- Assessment Tools in Juvenile Idiopathic Arthritis (2016) (0)
- [Juvenile dermatomyositis]. (1990) (0)
- THU0655 LONG-TERM OUTCOME OF JUVENILE IDIOPATHIC ARTHRITIS: COMPARISON OF BIOLOGIC AND METHOTREXATE ERAS (2019) (0)
- [The so-called Friedrich's disease]. (1955) (0)
- Analysis of arthritis flares after achievement of inactive disease with methotrexate monotherapy in juvenile idiopathic arthritis. (2020) (0)
- [Radiography of chalky-white bile]. (1949) (0)
- Defining clinical remission and clinically inactive disease in juvenile systemic lupus erythematosus (jSLE) (2011) (0)
- [Cancer of pancreas metastatic to the abdominal wall]. (1955) (0)
- AB0090 INHERITED DEFICIT OF PROTEOGLYCAN MIMICKING SEPTIC ARTHRITIS (2019) (0)
- ANTINUCLEAR ANTIBODY POSITIVITY IS THE BEST PREDICTOR OF RESPONSE TO METHOTREXATE IN JUVENILE IDIOPATHIC ARTHRITIS. ANALYSIS OF THE PRINTO TRIAL: 39 (2006) (0)
- [Not Available]. (1947) (0)
- The PRINTO juvenile dermatomyositis trial – Authors' reply (2016) (0)
- Evaluation of the disease course of Italian children with juvenile idiopathic arthritis treated with etanercept: preliminary results in 772 patients (2014) (0)
- [Simulated duplication of the gallbladder]. (1955) (0)
- [Not Available]. (1948) (0)
- CS-10 Criteria for clinically relevant improvement in children & adolescents with childhood-onset systemic lupus erythematosus (2018) (0)
- Validation of Flare Criteria for Children and Adolescents with Systemic Lupus Erythematosus (2017) (0)
- THU0498 PATIENT-REPORTED TREATMENT BURDEN AND ITS IMPACT ON QUALITY OF LIFE IN JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM THE PHARMACHILD REGISTRY (2020) (0)
- Abstract withdrawn (2005) (0)
- [Brown tumors]. (1954) (0)
- [Anatomical and roentgenological studies of the wrist]. (1955) (0)
- [70th anniversary of Ernst Ruckensteiner]. (1969) (0)
- [Measurement of the acetabular angle in newborn]. (1953) (0)
- UNUSUAL CUTANEOUS FEATURES OF RHEUMATOLOGIC DISEASES OF CHILDHOOD: A CLINICOPATHOLOGICAL APPROACH.: 17 (1997) (0)
- [Ossification of the carpus]. (1952) (0)
- Development of an internationally agreed minimal dataset for juvenile dermatomyositis (2014) (0)
- PReS-FINAL-2176: Declines in levels of disease activity and physical disability in children with juvenile idiopathic arthritis seen in standard clinical care over the last 25 years (2013) (0)
- ANTIPHOSPHOLIPID ANTIBODY SYNDROME AS A CAUSE OF VENOUS THROMBOSIS IN CHILDHOOD. AUTHORS' REPLY (1994) (0)
- [Osteochondritis dissecans of the fibular femoral condyle]. (1951) (0)
- [Roentgenography of traumatic aneurysms]. (1950) (0)
- [Transient protein-losing hypertrophic gastropathy in children. Description of 2 clinical cases and review of the literature]. (1987) (0)
- [Conic epiphyses of the central phalanges of the toes]. (1956) (0)
- 53 – Juvenile idiopathic arthritis (2008) (0)
- Abstract withdrawn (2011) (0)
- [Primary tuberculous focus in the apex of the left lung]. (1950) (0)
- Psoriasis and Psoriatic Arthritis. (1955) (0)
- [Solitary cartilaginous exostoses]. (1955) (0)
- [Stump of the appendix in the cecum]. (1950) (0)
- Dr. Tibaldi, et al reply (2019) (0)
- Systemic vasculitis followed by chronic myelogenous leukemia. (1988) (0)
- SAT0488 Therapy-Induced Changes in Us-Detected Synovial Abnormalities in Juvenile Idiopathic Arthritis (2015) (0)
- PReS-FINAL-2164: Agreement among musculoskeletal pediatric specialists in the assessment of radiographic joint damage in juvenile idiopathic arthritis (2013) (0)
- A comparison of clinical vs ultrasound determined synovitis in juvenile idiopathic arthritis (JIA) (2008) (0)
- [Anatomical and roentgenological picture of tibial tuberosity in adults]. (1955) (0)
- Grading of joint indices for severity reflects better the burden of joint disease and its impact on child's well-being in juvenile idiopathic arthritis (JIA) (2008) (0)
- PW01-039 – Long-term efficacy of anakinra in SoJIA patients (2013) (0)
- [Roentgenography of spiral fractures of the leg (eversion and inversion fracture)]. (1952) (0)
- SHARE – workpackage 5 : evidence based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus (2014) (0)
- [Not Available]. (1948) (0)
- [Not Available]. (1955) (0)
- Development and initial validation of a new short and simple Health-Related Quality Of Life (HRQL) Questionnaire for Pediatric Rheumatic Diseases (PRD) (2008) (0)
- AB0972 DEVELOPMENT OF THE PARENT VERSION OF THE JUVENILE ARTHRITIS DISEASE ACTIVITY SCORE CUT-OFFS FOR MODERATE AND HIGH DISEASE ACTIVITY STATES IN JUVENILE IDIOPATHIC ARTHRITIS IN A LARGE MULTINATIONAL PATIENT SAMPLE (2020) (0)
- [Calcaneal triangle as a site of hematoma cysts]. (1953) (0)
- [Rupture of diaphragm under the guise of pleuritis]. (1953) (0)
- [The anatomic and radiologic picture of the acetabulum (author's transl)]. (1975) (0)
- [Not Available]. (1948) (0)
- AB0992 CONNECTING SLEEP QUALITY, PAIN AND MOOD DISTURBANCES IN JUVENILE FIBROMYALGIA (2020) (0)
- [Polyp of the stomach misdiagnosed as source of hemorrhage]. (1953) (0)
- [A fibroma of skin of back presented as round shadow in roentgen picture of thorax]. (1955) (0)
- Dissecting the heterogeneity of macrophage activation syndrome (2014) (0)
- [Vascular channels in carpal bones]. (1953) (0)
- Pediatric systemic multi-inflammatory diseases in Italy during SARS-COV-2 epidemic: From Kawasaki disease to Kawacovid (2020) (0)
- Validation of Clinically Relevant Improvement in Children and Adolescents with cSLE (2017) (0)
- PReS-FINAL-2141: Clinical features, therapeutic interventions and outcome of 362 patients with macrophage activation syndrome enrolled in a multinational survey (2013) (0)
- [Radiogram of the ligament groove at the sternal end of the clavicle]. (1955) (0)
- POS0339 POINTS TO CONSIDER AT THE EARLIEST STAGES OF THE DIAGNOSIS AND MANAGEMENT OF HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS/MACROPHAGE ACTIVATION SYNDROME (HLH/MAS) (2022) (0)
- Myelomonocytic cells in giant cell arteritis activate trained immunity programs sustaining inflammation and cytokine production. (2023) (0)
- SHARE – workpackage 5: evidence based recommendations for diagnosis and treatment of juvenile localized scleroderma and juvenile systemic sclerosis (2014) (0)
- Type I interferon activation in RAS-associated autoimmune leukoproliferative disease (RALD). (2021) (0)
- PReS-FINAL-2193: Assessment of construct validity of new measures of global disease activity, physical function and quality of life in children with juvenile dermatomyositis (2013) (0)
- Differences in therapeutic approach to juvenile dermatomyositis between Europe and Latin America (2008) (0)
- A new approach to defining inactive disease, minimal disease activity and parent- and child-acceptable symptom state in juvenile idiopathic arthritis (2011) (0)
- Pulmonary function inchildren withsystemic lupuserythematosus (1996) (0)
- [Malformations of arch and joint processes of the lumbar vertebrae]. (1955) (0)
- Evidence for charge-based mimicry in anti dsDNA antibody generation. (2022) (0)
- [Glomus tumors in unusual sites]. (1976) (0)
- POS0334 DRIVERS OF NON-ZERO PHYSICIAN GLOBAL SCORES DURING PERIODS OF INACTIVE DISEASE IN JUVENILE IDIOPATHIC ARTHRITIS (2022) (0)
- chronic arthritis . disease activity in juvenile subclass concentrations with Variation of serum IgG (2004) (0)
- Imaging in pediatric rheumatic diseases (2016) (0)
- Abstract withdrawn (2013) (0)
- THU0507 TYPE I INTERFERON SCORE AND INTERFERON INDUCED MEDIATORS CXCL10 AND NEOPTERIN ARE CORRELATED WITH DISEASE ACTIVITY IN JUVENILE DERMATOMYOSITIS (2019) (0)
- [Tuberculous focus in skull cap]. (1953) (0)
- 2021 ACR guideline for JIA reflects changes in practice (2022) (0)
- [Not Available]. (1948) (0)
- OP0150 Development and Preliminary Validation of a New Composite Disease Activity Measure for Juvenile Dermatomyositis (2015) (0)
- SAT0501 THE IMPACT OF MORNING STIFFNESS ON THE DEFINITION OF INACTIVE DISEASE IN JUVENILE IDIOPATHIC ARTHRITIS (2019) (0)
- SAT0446 A Meta-Analysis to Assess the “Real” Placebo Effect in Juvenile Idiopathic Arthritis (JIA) (2013) (0)
- [Area of attachment of the costoclavicular ligament to the clavicle]. (1955) (0)
- Therapeutic approaches for the treatment of new onset and flared juvenile systemic lupus erythematosus with active renal disease: an international multicenter PRINTO study (2011) (0)
- Drivers of non-zero physician global scores during periods of inactive disease in juvenile idiopathic arthritis (2022) (0)
- Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part three (2017) (0)
- Quantitative assessment of synovitis in juvenile idiopathic arthritis using Dynamic Contrast-Enhanced Magnetic Resonance Imaging (2008) (0)
- [Lung foci and osteomyelitis]. (1954) (0)
- Nearly 20% of children are not correctly classified according to current ilar classification in a PRINTO dataset of more than 12,000 juvenile idiopathic arthritis patients (2014) (0)
- Outcome, Prognosis and Future Outlook (2016) (0)
- [Roentgenography of intrathoracic paravertebral neuroma]. (1950) (0)
- O43 5-Year Data from Tender, a Phase III Clinical Trial: Safety and Efficacy of Tocilizumab in Patients with Systemic Juvenile Idiopathic Arthritis (2016) (0)
- Clinical evaluation of sulbactam plus ampicillin in the treatment of general pediatric infections. (1989) (0)
- LA SINDROME DA ANTIFOSFOLIPIDI (1995) (0)
- [Partial sclerosis of the scaphoid bone of the wrist]. (1956) (0)
- [Vesicular opacity of iodobil in the stomach]. (1954) (0)
- Juvenile Psoriatic Arthritis: Myth or Reality? An Unending Debate (2023) (0)
- [Penetration of calcium pulp into the bursa subdeltoidea]. (1955) (0)
- Factors Associated with Etoposide usage in Children with Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis (2016) (0)
- THU0521 The Methotrexate Treatment can Prevent Uveitis Onset in Juvenile Idiopathic Arthritis: The Experience in Cohort with Increased Proportion of Methotrexate (2015) (0)
- [So-called osteitis condensans ossis ilium (parasacral iliac sclerosis]. (1954) (0)
- Paediatric rheumatic disease: What is the best definition of clinical remission in JIA? (2017) (0)
- [Traumatic arteriovenous aneurysm of a pulmonary vessel]. (1954) (0)
- Share – Workpackage 5: evidence based recommendations for diagnosis and treatment of juvenile idiopathic arthritis (2014) (0)
- POS0071 IS ANTI-NXP2 AUTOANTIBODY A RISK FACTOR FOR CALCINOSIS AND POOR OUTCOME IN JUVENILE DERMATOMYOSITIS PATIENTS? (2021) (0)
- Protection against MIS-C outweighs the risk of myocarditis after Covid-19 vaccination in children (2022) (0)
- PReS-endorsed international childhood lupus T2T task force definition of childhood lupus low disease activity state (cLLDAS). (2023) (0)
- PReS-FINAL-2028: ANA positivity and a younger age at onset, but not disease category, predict the risk of uveitis in italian children with juvenile idiopathic arthritis (2013) (0)
- SAT0447 Preliminary Definition of Cutoffs for High Disease Activity Based on Original and Simplified Jadas in Juvenile Idiopathic Arthritis (2013) (0)
- [Torsion and frontal curvature of the clavicle]. (1955) (0)
- [Ossification of the ossa multangula]. (1955) (0)
- SAT0511 CANAKINUMAB IN SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: CLINICAL INACTIVE DISEASE RATE AND SAFETY IN ITALIAN PATIENTS (2019) (0)
- Pediatric rheumatology Cyclosporine A in juvenile idiopathic arthritis. Results of the PRCSG/PRINTO phase IV post marketing surveillance study (2006) (0)
- [A new computerized file of juvenile rheumatoid arthritis]. (1989) (0)
- Vaccinations in pediatric patients receiving DMARDs, glucocorticosteroids or biological therapy (2011) (0)
- OP0135 Clinical and therapeutic features of 270 patients with macrophage activation syndrome enrolled in a multinational survey (2013) (0)
- [Not Available]. (1948) (0)
- [The so-called osteoid osteoma Jaffé; (a preliminary review)]. (1955) (0)
- Variation ofserum IgGsubclass concentrations with disease activity injuvenile chronic arthritis (1989) (0)
- OP0161 PREDICTIVE VALUE OF MUSCULOSKELETAL ULTRASOUND IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS IN CLINICAL REMISSION (2021) (0)
- [Roentgenography of spiral fractures in the young]. (1952) (0)
- [Os accessorium supracalcaneum; final comment on the reply of K. Kremser]. (1956) (0)
- Chapter 4 Macrophage Activation Syndrome (2007) (0)
- SHARE – workpackage 5: evidence based recommendations for diagnosis and treatment of the antiphospholipid syndrome (2014) (0)
- [Not Available]. (1949) (0)
- SAT0490 Development of an Internationally Agreed Minimal Dataset for Juvenile Dermatomyositis (JDM) for Clinical and Research Use (2015) (0)
- [Solitary round shadows in roentgenograms of the thorax]. (1951) (0)
- Diagnostic imaging in infantile polycystic kidney disease. Presentation of two cases. (1987) (0)
- [Injury of the calcaneum caused by overstrain in a young woman]. (1955) (0)
- 159 Systemic Lupus Erythematosus (2012) (0)
- IMACS and ACR JDM Working Group Joint Breakfast Meeting (2005) (0)
- POS0173 DATA-DRIVEN MRI DEFINITIONS FOR ACTIVE AND STRUCTURAL SACROILIAC JOINT LESIONS IN JUVENILE SPONDYLOARTHRITIS TYPICAL OF AXIAL DISEASE (2022) (0)
- AB1178 Comparison of the prevalence of proxy- or self-reported side effects of methotrexate administered orally, subcutaneously or intramuscularly in children with juvenile idiopathic arthritis (2013) (0)
- 2.4 Magnetic resonance imaging, ultrasonography and conventional radiography in the assessment of bone erosions in juvenile idiopathic arthritis (2008) (0)
- 3.5 Comparison of functional ability in juvenile idiopathic arthritis, juvenile dermatomyositis, juvenile systemic lupus erythematosus and healthy controls. An analysis of the PRINTO database (2008) (0)
- Paediatric rheumatology Performance of the Birmingham Vasculitis Activity Score and Disease Extent Index in childhood vasculitides (2012) (0)
- [Spontaneous fracture of a carious rib]. (1954) (0)
- [Monteggia's fracture and its counterpart]. (1954) (0)
- Reply to letter by Isenberg and Gordon commenting on the Pediatric Rheumatology International Trials Organization criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus. (2006) (0)
- SAT0451 Methotrexate Therapy may Prevent the Onset of Uveitis in Juvenile Idiopathic Arthritis (2013) (0)
- [A peculiar form of the sternal end of the clavicle (fish mouth form)]. (1955) (0)
- [Aseptic osteonecrosis of the acromial epiphysis; remarks on the article of E. de Cuveland (Fortschr. Röntgenstr. 83 (1955), p. 120)]. (1956) (0)
- Se la parotide non si gonfia una volta sola (2001) (0)
- SAT0669 DISCRIMINANT ABILITY OF THE PARENT VERSION OF THE JUVENILE ARTHRITIS DISEASE ACTIVITY SCORE IN A LARGE MULTINATION COHORT OF PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS (2019) (0)
- [Delay of gallbladder filing by contrast medium retention in stomach]. (1956) (0)
- The Croatian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) (2018) (0)
- Proteomic profiling of extracellular vesicles in synovial fluid and plasma from Oligoarticular Juvenile Idiopathic Arthritis patients reveals novel immunopathogenic biomarkers (2023) (0)
- [Bony metastases of the thyroid tissue; metastasizing adenoma and struma]. (1952) (0)
- FRI0571 MEASUREMENT PERFORMANCE OF REDUCED VERSIONS OF MUSCLE STRENGTH TOOLS IN JUVENILE DERMATOMYOSITIS (2019) (0)
- PP11. Assessment of radiographic progression in patients with systemic juvenile idiopathic arthritis treated with tocilizumab: 2-year data from tender (2015) (0)
- [The question of so-called osteochondritis dissecans of the supratrochlear septum]. (1955) (0)
- [Base line of the Y-angle as an aid in the early diagnosis of congenital dislocation of the hip]. (1953) (0)
- AB1316 AGREEMENT BETWEEN SUBJECTIVE AND OBJECTIVE DEFINITIONS OF INACTIVE DISEASE IN CHILDREN WITH JUVENILE IDIOPATHIC ARHRITIS (2019) (0)
- [Pediatric digestive endoscopy: personal experience]. (1983) (0)
- [Strain injuries of the tibia in a child]. (1955) (0)
- PReS-FINAL-2167: What is the potential of intra-articular corticosteroid injections to induce sustained remission in children with juvenile idiopathic arthritis? (2013) (0)
- [Osteochondrosis dissecans of the head of the first metatarsal]. (1952) (0)
- Clinical factors distinguishing between pediatric tumors with arthritis at onset and JIA: preliminary analysis of the ONCOREUM study (2019) (0)
- PReS13-SPK-1332: Assessment of disease activity and damage in juvenile idiopathic arthritis (2013) (0)
- [The problem of the so-called Os accessorium supracalcaneum]. (1955) (0)
- [On Besnier-Boeck-Schaumann disease of the lung; epithelial cell tuberculosis, atypical tuberculosis]. (1953) (0)
- [Persisting apophysis of processus coracoideus scapulae]. (1956) (0)
- DIFFERENT HISTOLOGICAL CLASSIFICATIONS FOR HENOCH-SCHÖNLEIN PURPURA NEPHRITIS - WHICH ONE IS THE BEST PREDICTOR OF DISEASE OUTCOME? PILOT STUDY OF THE PRES VASCULITIS WORKING PARTY (2020) (0)
- 443 Different histological classifications for IgA vasculitis nephritis – which one has the best association with the disease outcome? (2021) (0)
- [Rare localization of peritendinitis calcarea]. (1953) (0)
- THU0502 Which is the Clinical Relevance of Ultrasound Examination in the Assessment of Established Juvenile Idiopathic Arthritis? (2015) (0)
- OP0270 Further Validation of the Hybrid MMT/CMAS (HMC), A New Measure of Muscle Disease Activity in Juvenile Dermatomyositis (2015) (0)
- [To Dr. Ernst Ruckensteiner on his 60th birthday]. (1959) (0)
- [Sclerosing nonsuppurative form of osteomyelitis Garrè]. (1955) (0)
- OA39 Development of a Childhood Lupus Low Disease Activity State definition: recommendations from the International Childhood Lupus Treat-to-Target Task Force (2023) (0)
- OP0340 Evidence based recommendations for corticosteroid tapering/discontinuation in new onset juvenile dermatomyositis patients from the printo trial (2018) (0)
- Does the perception of health related quality of life (hrql) in children with juvenile idiopathic arthritis (JIA) change among different cultures (2005) (0)
- [The vacuum phenomenon (R. Kick's sign)]. (1955) (0)
- SP0138 The Long Term Outcome of Juvenile Idiopathic Arthritis (2013) (0)
- The PRINTO provisional definition of remission in juvenile dermatomyositis (2011) (0)
- [Nomenclature of angles in the lumbo-sacral region (author's transl)]. (1975) (0)
- Advanced bone age in the affected side predicts worse radiographic progression in patients with juvenile idiopathic arthritis and unilateral wrist disease (2014) (0)
- A multivariate analysis of pulmonary function measurements in a sample of healthy children (1991) (0)
- OP-BRHE140267 1..2 (2014) (0)
- Abstract withdrawn (2013) (0)
- [Not Available]. (1947) (0)
- THU0298 SWITCH OR SWAP STRATEGY IN TAKAYASU ARTERITIS PATIENTS FAILING TNFA INHIBITORS? (2020) (0)
- [Supranavicular bone and cartilaginous exostosis of the tibia]. (1955) (0)
- [Not Available]. (1947) (0)
- [Attempted embryological interpretation of specific details of clavicle and its junctions]. (1955) (0)
- On the creation of the Ludloff spot. (1948) (0)
- Correction: 2016 American college of rheumatology/European league against rheumatism criteria for minimal moderate, and major clinical response in juvenile dermatomyositis (2018) (0)
- Comparison of physician's, parent's and patient's global ratings made on linear or 21-circle visual analogue scales (VAS) in juvenile idiopathic arthritis (JIA) (2008) (0)
- PReS-FINAL-2102: Comparison of sensitivity and specificity of MAS and HLH diagnostic guidelines in 362 children with MAS complicating systemic JIA (2013) (0)
- 8.5 Predictors of long-term outcome of Juvenile Dermatomyositis (JDM): a Multicenter, Multinational Study of 490 patients (2008) (0)
- [Significance and nomenclature of superflous carpal elements]. (1956) (0)
- lupus erythematosus . Pulmonary function in children with systemic (0)
- Intra- and Juxta-Articular Osteoid Osteoma Mimicking Arthritis: Case Series and Literature Review (2023) (0)
- OP0215 WHAT DOES THE PATIENT WELL-BEING VAS TELL US WHEN THE PHYSICIAN GLOBAL ASSESSMENT SCORE IS ZERO? ANALYSIS OF A LARGE MULTINATIONAL DATASET (2022) (0)
- SAT0486 Macrophage Activation Syndrome and Familial Hemophagocytic Lymphohistiocytosis: Is Their Clinical Phenotype Really Similar? (2015) (0)
- Artificial intelligence and high-dimensional technologies in the theragnosis of systemic lupus erythematous (2023) (0)
- [Angulation of the femoral neck in man, especially in newborn]. (1953) (0)
- [Osteoid osteoma Jaffé and two non-ossifying osteoid Jaffé-Lichtenstein fibromas at the same femur]. (1956) (0)
- THU0594 CLINICAL VERSUS IMAGING REMISSION IN JUVENILE IDIOPATHIC ARTHRITIS (JIA): PRELIMINARY RESULTS OF THE REMECO STUDY (2019) (0)
- PROMs for Juvenile Idiopathic Arthritis (2016) (0)
- [Roentgen picture and interpretation of certain bone foci in certain metaphyses of tibia and femur; metaphysal cortical giant cell granuloma]. (1955) (0)
- [Aztreonam in the treatment of infections of the urinary tract in childhood]. (1985) (0)
- [The picture of the osseous deforming arthropathy]. (1955) (0)
- PReS-FINAL-2174: The performance of the new slicc criteria for the classification of sle in children (2013) (0)
- [On the genesis of the supranavicular bone]. (1955) (0)
- Musculoskeletal symptoms at the onset of pediatric tumors and predictive features in the differential diagnosis with juvenile idiopatic arthritis: preliminary analysis of a multicenter, prospective, observational study (2017) (0)
- SHARE – workpackage 5: evidence based recommendations for diagnosis and treatment of juvenile dermatomyositis (2014) (0)
- Classification criteria for chronic arthritis in children: a work in progress. (2022) (0)
- [Roentgenography of isolated fracture of spinal processes of the cervicothoracic spine]. (1954) (0)
- X-Ray Appearances of the Higher Animal Parasites in the Human Lung. (1949) (0)
- [The late stage of tuberculous coxitis]. (1952) (0)
- [Not Available]. (1948) (0)
- Analysis of ceiling effect and score distribution of outcome measures in juvenile idiopathic arthritis (JIA) (2008) (0)
- Hip in Juvenile Idiopathic Arthritis Development and Initial Validation of a Radiographic Scoring System for the (2010) (0)
- [Typhoid periostitis or osteomyelitis]. (1955) (0)
- PReS-FINAL-2098: Evaluation of the disease course of Italian children with juvenile idiopathic arthritis treated with etanercept: preliminary results in 313 patients (2013) (0)
- [Multiple processus styloidei at the lumbar spine]. (1954) (0)
- [On osteochondrolysis dissecans of the knee joint]. (1951) (0)
- Growth and Puberty in Juvenile Dermatomyositis a Longitudinal Multinatinal Cohort Study (2017) (0)
- SAT0524B THE HETEROGENEITY OF JUVENILE PSORIATIC ARTHRITIS: EVIDENCE FROM A LARGE MULTINATIONAL COHORT (2019) (0)
- Comparison of the accuracy of different definitions of clinical remission (CR) and minimal disease activity (MDA) in juvenile idiopathic arthritis (JIA) (2008) (0)
- [Parasternal ossicum]. (1956) (0)
- SAT0455 Preliminary Validation of a New Hybrid Measure of Muscle Strength for Juvenile Dermatomyositis (2013) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Angelo Ravelli?
Angelo Ravelli is affiliated with the following schools:
